Atlas Trials

Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time

Clinical trial NCT01223365 · COMPLETED

Trial details

NCT number
NCT01223365
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Pain
Start date
2010-10-01
Primary completion
2012-09-01
Enrollment
330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.